Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2007 Jan 12;44(4):264–268. doi: 10.1136/jmg.2006.047860

Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14

Björn Menten 1,2,3,4, Karen Buysse 1,2,3,4, Farah Zahir 1,2,3,4, Jan Hellemans 1,2,3,4, Sara J Hamilton 1,2,3,4, Teresa Costa 1,2,3,4, Carrie Fagerstrom 1,2,3,4, George Anadiotis 1,2,3,4, Daniel Kingsbury 1,2,3,4, Barbara C McGillivray 1,2,3,4, Marco A Marra 1,2,3,4, Jan M Friedman 1,2,3,4, Frank Speleman 1,2,3,4, Geert Mortier 1,2,3,4
PMCID: PMC2598049  PMID: 17220210

Abstract

This report presents the detection of a heterozygous deletion at chromosome 12q14 in three unrelated patients with a similar phenotype consisting of mild mental retardation, failure to thrive in infancy, proportionate short stature and osteopoikilosis as the most characteristic features. In each case, this interstitial deletion was found using molecular karyotyping. The deletion occurred as a de novo event and varied between 3.44 and 6 megabases (Mb) in size with a 3.44 Mb common deleted region. The deleted interval was not flanked by low‐copy repeats or segmental duplications. It contains 13 RefSeq genes, including LEMD3, which was previously shown to be the causal gene for osteopoikilosis. The observation of osteopoikilosis lesions should facilitate recognition of this new microdeletion syndrome among children with failure to thrive, short stature and learning disabilities.

Keywords: osteopoikilosis, short stature, mental retardation, HMGA2 , GRIP1


Classical cytogenetic analysis has played an essential role in the discovery of recurrent segmental deletions in patients with clinically recognisable mental retardation such as Prader–Willi, Miller–Dieker, Langer–Giedion and velocardiofacial syndromes.1 The subsequent delineation of commonly deleted segments and mapping of small atypical deletions have allowed the identification of genes responsible for the major clinical features of these contiguous gene deletion syndromes.2 Recently, molecular karyotyping was proven to be a more powerful tool in detecting submicroscopic deletions or duplications in patients with so‐called idiopathic mental retardation with or without congenital malformations. Molecular karyotyping studies have shown that in about 10% of these cases segmental imbalances can be found.3,4,5,6,7,8,9 Using this new genome‐wide screening technology, new disease genes can be identified, as illustrated for the CHD7 gene in CHARGE syndrome.10 Very recently, some new microdeletion syndromes were identified using molecular karyotyping.11,12,13

Here, we report on three unrelated patients with de novo 12q14 microdeletions. They share osteopoikilosis, short stature and learning disabilities as common phenotypic features. In two cases the deletion was approximately 6 megabases (Mb) in size whereas in the third patient a 3.44 Mb deletion was detected.

The first proband (03g1858) is a girl born at term with a birth weight of 2060 g. Pregnancy and delivery were uneventful. At the age of 6 months, she presented with failure to thrive and by the age of 1 year, length, weight and head circumference were all far below the third centile. Work‐up for this failure to thrive only revealed hypertension, for which she received medication. The diagnosis of Russell‐Silver syndrome was considered at that time. The girl also showed delayed neuromotor development and experienced learning difficulties requiring an individualised programme at school. Clinical evaluation at the age of 16 years revealed proportionate short stature with a weight of 31.8 kg (−4 SDs), height of 131.5 cm (−6.2 SDs), span of 131 cm and head circumference of 49 cm (−4.4 SDs). The face was mildly dysmorphic with synophrys, mild hypertelorism, broad and high nasal bridge, micrognathia and maxillary overbite. These clinical features were not reminiscent of Russell‐Silver syndrome. Imaging studies revealed the presence of ectopic kidneys, and an aortogram showed on each side two renal arteries with an aberrant origin. In addition, malrotation of the small bowel, a medially positioned spleen and an unusually shaped (rectangular) liver were found. Radiographic evaluation showed multiple osteopoikilosis lesions in the pelvis, shoulders, wrists, hands and feet (fig 1A).

graphic file with name mg47860.f1.jpg

Figure 1 Clinical and radiographic features of the microdeletion syndrome. (A) Radiograph of the pelvis in patient 03g1858 showing multiple osteopoikilosis lesions in the proximal parts of the femurs and pubic bones. Facial phenotype of patient D0502619 with anteroposterior (B) and lateral (C) view (patients 03g1858 and #4818 refused clinical photographs). Parental/guardian informed consent was obtained for publication of this figure.

The second female proband (D0502619, figure 1B,C) was born at term with a weight of 2300 g. The pregnancy was complicated by oligohydramnios. The postnatal course was uneventful. Early in infancy very poor growth and development became apparent. At the age of 4 years she was diagnosed with scoliosis, type 1 Arnold‐Chiari malformation and ultimately syringomelia requiring a shunt. She also had a release for a tethered spinal cord. Reflux nephropathy with small kidneys, mild hypertension and diabetes mellitus were diagnosed in childhood. In school, mild learning problems became apparent, and therefore she was put on an individualised education plan. At the age of 14 years she presented with complaints of tingling pain in the medial part of her right foot. Clinical evaluation revealed a weight of 51.3 kg (mean for age), height of 142.3 cm (−3.5 SDs) and head circumference of 53.3 cm (−0.66 SDs). Her face was round with rather deep‐set eyes, bushy eyebrows and thin lips. (fig 1B,C). A thoracolumbar scoliosis was noted. The skin showed several areas of increased pigmentation. Mild swelling without other inflammatory signs was present on the right foot. The gait pattern was somewhat antalgic. Radiographic evaluation revealed numerous osteopoikilosis lesions in the distal part of the tibia and fibula as well as in the right foot. In addition, the second right metatarsal showed a thickened and irregular cortical lesion suggestive of melorheostosis at the diaphysis. At the age of nearly 16 years, she is now functioning at the level of a 10‐year‐old child. She is quite sociable and tends to be very articulate and repetitive.

The third patient (#4818) is the male product of the first pregnancy of an unrelated 22‐year‐old mother and 35‐year‐old father. The pregnancy was complicated by hyperemesis. There were no adverse exposures. The family history was non‐contributory. Delivery was at term with weight at the third centile and length at the tenth centile. The boy failed to thrive during the first year. At age three years six months, all growth measurements were below the third centile, and development was a year delayed. Growth hormone levels and bone age were normal. At age four, he was found to have delays in fine motor skills and speech. Six secondary teeth were missing on dental radiographs. After sustaining a fracture of the right tibia, he developed clawing of the toes and electromyogram findings suggestive of sciatic nerve injury. Radiographs documented osteopoikilosis lesions within multiple bones. When seen at 12 years of age, he was noted to have mild developmental delay, with difficulties in spelling and reading. He was tiny, with all growth measurements below the third centile. His face was triangular with widely spaced eyes. There were yellowish raised areas on the skin overlying the upper chest and flank. Trichothiodystrophy was considered as a diagnosis, but his hair was normal. He was reported to have a tremor that increased with writing. The patient was seen again at 18 years of age. His final height of 152 cm and weight of 41 kg were both below the third centile. He described a slow increase in tremor, most marked upon arising or intention. His overall health had been good, and he had achieved a normal puberty. He was entering grade 12, taking applied mathematics, and having problems with English.

The microdeletion in the first proband (03g1858) was identified during the course of mapping the gene for osteopoikilosis.14 The patient showed loss of heterozygosity for a stretch of markers in the linkage interval, which resulted in a considerable reduction of the critical region and finally led (through a candidate gene approach) to the identification of LEMD3 as the causal gene for osteopoikilosis. The deletion was confirmed with fluorescence in situ hybridisation (FISH) using BAC clone RP11‐305O6, as described by Van Roy et al.15 Breakpoints were further delineated using array CGH as described by Menten et al16 with a custom tiling path array for chromosomal bands 12q14–12q15. BAC clones were selected based upon the May 2004 human genome project assembly (http://genome.ucsc.edu/) (table 1, appendix).

Table 1 BAC clones used for breakpoint detection in patients 1 and 2, with their name, sanger name, chromosome, start position and end position according to the NCBI 36 genome assembly.

Name Sanger name Chromosome Start (base pairs) End (base pairs) Patient 1 Patient 2
RP11‐103L8 bA103L8 12 60326906 60482957 + +
RP11‐96F13 bA96F13 12 60399378 60556846 + +
RP11‐402I16 bA402I16 12 60470226 60639036 + +
RP11‐196A13 bA196A13 12 60516544 60670139 + +
RP11‐15P10 bA15P10 12 60592183 60768715 + +
RP11‐542G14 bA542G14 12 60637601 60804185 + +
RP11‐155D5 bA155D5 12 60695975 60861269 + +
RP11‐120M24 bA120M24 12 60829050 60980979 + +
RP11‐97A6 bA97A6 12 60917552 61052698 + +
RP11‐169M9 bA169M9 12 60920103 60948010 + +
RP11‐467D14 bA467D14 12 60966290 61162052 +
RP11‐142E5 bA142E5 12 61085454 61271298 +
RP11‐151H22 bA151H22 12 61221704 61367847 +
RP11‐570O18 bA570O18 12 61280315 61431623 +
RP11‐131G23 bA131G23 12 61343791 61525936 +
RP11‐538D3 bA538D3 12 61529122 61684800 +
RP11‐24L23 bA24L23 12 61634279 61805538
RP11‐263K23 bA263K23 12 61706479 61872677
RP11‐61L21 bA61L21 12 61883235 61951183
RP11‐105I10 bA105I10 12 61907586 62065780
RP11‐52P5 bA52P5 12 62021250 62183689
RP11‐267F23 bA267F23 12 62033781 62189805
RP11‐134D22 bA134D22 12 62196683 62347713
RP11‐272A21 bA272A21 12 62218641 62371090
RP11‐415I12 bA415I12 12 62349962 62538439
RP11‐367H3 bA367H3 12 62470168 62644125
RP11‐274J7 bA274J7 12 62508196 62670790
RP11‐456A6 bA456A6 12 62577649 62745265
RP11‐196H14 bA196H14 12 62738094 62928731
RP11‐290I21 bA290I21 12 62854244 62854997
RP11‐444B24 bA444B24 12 66740902 66931728
RP11‐71J4 bA71J4 12 66926693 67077364 +
RP11‐81H14 bA81H14 12 67059831 67208966 +
RP11‐185H13 bA185H13 12 67160267 67368737 +
RP11‐254B13 bA254B13 12 67191207 67347334 +
RP11‐531F4 bA531F4 12 67255471 67462087 +
RP11‐450G15 bA450G15 12 67366710 67543065 +
RP11‐410I6 bA410I6 12 67507773 67668188 +
RP11‐249J13 bA249J13 12 67574683 67726286 +
RP11‐43A22 bA43A22 12 67681180 67830736 + +
RP11‐324P9 bA324P9 12 67816914 68000647 + +
RP11‐73J11 bA73J11 12 67862072 68020699 + +
RP11‐426B12 bA426B12 12 67926203 68135266 + +
RP11‐159A18 bA159A18 12 68032940 68179706 + +
RP11‐23C15 bA23C15 12 68135291 68315468 + +
RP11‐15L3 bA15L3 12 68217524 68403913 + +
RP11‐161M18 bA161M18 12 68369051 68562065 + +
RP11‐21I1 bA21I1 12 68442353 68627676 + +
RP11‐21C8 bA21C8 12 68508458 68666217 + +
RP11‐384F11 bA384F11 12 68610540 68808607 + +
RP11‐60E14 bA60E14 12 68706960 68858931 + +

+, Presence of two copies; −, the BAC clone is deleted according to the array CGH profile.

After publication of the first patient, a second patient with a similar phenotype was identified. FISH with BAC clones RP11‐305O6 and RP11‐361O1 confirmed the presence of a microdeletion encompassing LEMD3 on chromosome 12. As in the first proband, the size of the deletion and the position of the breakpoints were determined by array CGH using a custom tiling path array with overlapping BAC clones (fig 2). The size of the deletion in the first two cases was similar (about 6 Mb) with an overlap of about 5.3 Mb. The genomic position of the deletion in patient 1 was slightly more telomeric than that in patient 2. Karyotyping and FISH of the parents of patients 1 and 2 yielded normal results, indicating that both deletions occurred de novo.

graphic file with name mg47860.f2.jpg

Figure 2 Chromosomal map of the deleted region with breakpoint flanking BAC clones for patients 1 and 2, breakpoint flanking SNP markers for patient 3, RefSeq genes (UCSC Genome Browser on Human Mar. 2006 Assembly) and segmental duplications. Karyotypes are written as: 46,XX,del(12)(q14.2q15).ish del(12)(q14.3)(RP11‐305O6‐) arr cgh 12q14.2q15(RP11‐24L23RP11‐249J13)x1 de novo for patient 1, 46,XX,del(12)(q14.1q15).ish del(12)(q14.3)(RP11‐305O6‐,RP11‐361O1‐) arr cgh 12q14.1q15(RP11‐467D14 RP11‐444B24)x1 de novo for patient 2 and 46,XX,del(12)(q14.2q15). arr cgh 12q14.2q15(rs10506536 rs10492198)x1 de novo for patient 3.

The microdeletion in the third patient (#4818) was identified during a study of 100 children with idiopathic mental retardation and normal standard chromosomal analysis, using Affymetrix GeneChip® Human Mapping 100K arrays.9 Breakpoints were mapped to SNP rs10506536 (63342649 base pairs) and SNP rs10492198 (66780095 base pairs), indicating a 3.44 Mb deletion. Affymetrix Genechip® analysis of the parents yielded normal results, indicating that this deletion also occurred de novo. The deletion in the child was confirmed by FISH using BAC RP11‐91K23. This deletion is smaller but lies entirely within the 5.3 Mb region that was deleted in both patients 1 and 2 (fig 2).

Segmental duplications or low copy repeats have been shown to play an important role in the formation of recurrent microdeletion syndromes by non‐allelic homologous recombination.17,18,19,20 However, no evidence of segmental duplications or low‐copy repeats was found near any of the six breakpoints in these three patients. Microdeletions may also occur without involvement of low copy repeats.12,21,22,23 Recent reviews estimate that only 25–50% of copy‐number variants are associated with segmental duplications.24 Recurrent microdeletions that are not associated with low‐copy repeats usually have different breakpoints in each case. They most likely result from breakage with subsequent nonhomologous endjoining. Given the apparent absence of low copy repeats near the 12q breakpoints described here, we suspect that a mechanism of nonhomologous endjoining may be responsible for occurrence of the microdeletions in our three cases.

In 1995, Jurenka and Van Allen reported a patient with mental retardation, short stature and a mixed sclerosing bone dysplasia reminiscent of melorheostosis.25 We suspect that this patient may have the same microdeletion as found in our three probands. Unfortunately, no DNA from this patient was available to test this hypothesis.

The similar phenotype in our three probands is remarkable. All three patients had a low birth weight and presented in infancy with failure to thrive. They subsequently showed delayed neuromotor development and finally mild mental retardation. They do not show a remarkable facial dysmorphism but all have a proportionate short stature with osteopoikilosis lesions on skeletal radiographs. One patient (#D0502619) developed a melorheostosis lesion in the foot. We have shown in previous studies that loss‐of‐function mutations in the LEMD3 gene can result in osteopoikilosis and/or melorheostosis lesions.14,26 However, failure to thrive, short stature and mental retardation are not observed in patients with either osteopoikilosis or melorheostosis. These findings must therefore be the result of haploinsufficiency for other contiguous genes in the microdeletion interval. In the common deleted region two interesting genes (HMGA2 and GRIP1) reside, which may account for these additional clinical problems in our patients (fig 2).

HMGA2 codes for an architectural factor belonging to the high‐mobility group (HMG) of proteins. It is characterised by three conserved DNA‐binding domains, AT hooks and an acidic C‐terminal tail. This gene product is involved in DNA packaging and plays an important role as a transcription factor in gene regulation.27 Recently, HMGA2 was described as the putative causal gene in a patient with overgrowth, lipomas and a de novo pericentric inversion of chromosome 12.28 Battista et al reported a murine model with a constitutively expressed truncated form of Hmga2, which led to gigantism associated with lipomatosis. The authors proposed that disruption of the Hmga2 gene led to upregulated expression.29 Disruptions and rearrangements of HGMA2 leading to aberrant gene expression are a frequent observation in lipomas and other benign mesenchymal tumours.30,31,32,33,34,35,36,37 Overexpression has also been reported in malignant tumours.38 Interestingly, Zhou et al. reported a “pygmy” phenotype in Hmga2−/− murine models,39 with heterozygous mice displaying a milder phenotype (80% of the weight of wild‐type mice).40 Taken together, these data are consistent with an important role for HMGA2 in growth. Hence, haploinsufficiency of this gene may result in short stature as observed in our patients. To test this hypothesis, a series of patients with idiopathic proportionate short stature will be tested for loss‐of‐function mutations in the HMGA2 gene.

Glutamate receptor interacting protein 1 (GRIP1) is a good candidate gene for mental retardation. GRIP1 is highly expressed in adult human and fetal brain as well as in other organ systems. The gene produces three different transcripts by alternative splicing and contains seven highly conserved domains. All GRIP1 products contain the PDZ domain, which is important in synaptic function.41GRIP1 proteins localise through their PDZ domains to α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) receptors in cultured rat hippocampal neurons.42,43 These AMPA receptors mediate synaptic transmission through glutamate, the major excitatory neurotransmitter in the central nervous system. GRIP1 is implicated in targeting AMPA receptors to the synapse.42,44,45GRIP1 is also involved in the induction of long‐term potentiation in rat hippocampal mossy fibres.46 In addition to their role in glutamergic synaptic transmission, GRIP1 products also localise to GABAergic synapses in rat hippocampal cultures and intact rat brain.47,48 Homozygous Grip1 knockout mice die as embryos.49 The heterozygous Grip1 knockout mouse phenotype has not yet been reported. The observations that GRIP1 codes for a non‐redundant protein that it is highly expressed in fetal and adult human brain, and involved in glutamergic synaptic transmission, support the possibility that GRIP1 haploinsufficiency caused the learning problems in our patients.

We conclude that we have identified a newly recognisable microdeletion syndrome involving chromosome 12q14. The clinical phenotype is mainly characterised by mild mental retardation, low birth weight with failure to thrive in early infancy and proportionate short stature. The osteopoikilosis lesions on skeletal radiographs are the most distinguishing feature of this microdeletion syndrome that should facilitate recognition of this peculiar disorder among children with mental retardation and growth failure.

Acknowledgements

We are grateful to the patients and their families for their cooperation. We thank the Mapping Core and Map Finishing groups of the Wellcome Trust Sanger Institute for initial clone supply and verification, and Ivy Jennes for technical assistance. This work was made possible by grants G.0200.03 from the FWO and GOA‐grant 12051203 from Ghent University.

Karen Buysse is a Research Assistant of the Research Foundation – Flanders (FWO – Vlaanderen). Jan Hellemans is funded by the Institute for the Promotion of Innovation by Science and Technology in Flanders. Marco Marra is a Scholar of the Michael Smith Foundation for Health Research. This study is supported, in part, by the Fund for Scientific Research, Flanders, with a grant for fundamental clinical research to GRM.

This text presents research results of the Belgian program of Interuniversity Poles of attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming (IUAP).

Abbreviations

FISH - fluorescence in situ hybridisation

Mb - megabase

Footnotes

Parental/guardian informed consent was obtained for publication of figure 1.

References

  • 1.Schinzel A. Microdeletion syndromes, balanced translocations, and gene mapping. J Med Genet 198825454–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schmickel R D. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr 1986109231–241. [DOI] [PubMed] [Google Scholar]
  • 3.de Vries B B, Pfundt R, Leisink M, Koolen D A, Vissers L E, Janssen I M, Reijmersdal S, Nillesen W M, Huys E H, Leeuw N, Smeets D, Sistermans E A, Feuth T, van Ravenswaaij‐Arts C M, van Kessel A G, Schoenmakers E F, Brunner H G, Veltman J A. Diagnostic genome profiling in mental retardation. Am J Hum Genet 200577606–616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, Melotte C, de Ravel T, Van Vooren S, Balikova I, Backx L, Janssens S, De Paepe A, De Moor B, Moreau Y, Marynen P, Fryns J P, Mortier G, Devriendt K, Speleman F, Vermeesch J R. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 200643625–633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rosenberg C, Knijnenburg J, Bakker E, Vianna‐Morgante A M, Sloos W, Otto P A, Kriek M, Hansson K, Krepischi‐Santos A C, Fiegler H, Carter N P, Bijlsma E K, van Haeringen A, Szuhai K, Tanke H J. Array‐CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet 200643180–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid B M, Nordenskjold M. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array‐CGH). J Med Genet 200542699–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shaw‐Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, Firth H, Sanlaville D, Winter R, Colleaux L, Bobrow M, Carter N P. Microarray based comparative genomic hybridisation (array‐CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 200441241–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vissers L E, de Vries B B, Osoegawa K, Janssen I M, Feuth T, Choy C O, Straatman H, van der Vliet W, Huys E H, van Rijk A, Smeets D, van Ravenswaaij‐Arts C M, Knoers N V, van der Burgt I, de Jong P J, Brunner H G, van Kessel A G, Schoenmakers E F, Veltman J A. Array‐based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003731261–1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Friedman J M, Baross A, Delaney A D, Ally A, Arbour L, Asano J, Bailey D K, Barber S, Birch P, Brown‐John M, Cao M, Chan S, Charest D L, Farnoud N, Fernandes N, Flibotte S, Go A, Gibson W T, Holt R A, Jones S J, Kennedy G C, Krzywinski M, Langlois S, Li H I, McGillivray B C, Nayar T, Pugh T J, Rajcan‐Separovic E, Schein J E, Schnerch A, Siddiqui A, Van Allen M I, Wilson G, Yong S L, Zahir F, Eydoux P, Marra M A. Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 200679500–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Vissers L E, Veltman J A, van Kessel A G, Brunner H G. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 200514(Spec No. 2)R215–R223. [DOI] [PubMed] [Google Scholar]
  • 11.Koolen D A, Vissers L E, Pfundt R, de Leeuw N, Knight S J, Regan R, Kooy R F, Reyniers E, Romano C, Fichera M, Schinzel A, Baumer A, Anderlid B M, Schoumans J, Knoers N V, van Kessel A G, Sistermans E A, Veltman J A, Brunner H G, de Vries B B. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 200638999–1001. [DOI] [PubMed] [Google Scholar]
  • 12.Redon R, Baujat G, Sanlaville D, Le Merrer M, Vekemans M, Munnich A, Carter N P, Cormier‐Daire V, Colleaux L. Interstitial 9q22. 3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome, Eur J Hum Genet 200614759–767. [DOI] [PubMed] [Google Scholar]
  • 13.Shaw‐Smith C, Pittman A M, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi‐Santos A C, Varela M C, Koiffmann C P, Lees A J, Rosenberg C, Firth H V, de Silva R, Carter N P. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 2006381032–1037. [DOI] [PubMed] [Google Scholar]
  • 14.Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk P C, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen S J, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert J M, Vandesompele J, Speleman F, Verschueren K, Coucke P J, Mortier G R. Loss‐of‐function mutations in LEMD3 result in osteopoikilosis, Buschke‐Ollendorff syndrome and melorheostosis. Nat Genet 2004361213–1218. [DOI] [PubMed] [Google Scholar]
  • 15.Van Roy N, Laureys G, Cheng N C, Willem P, Opdenakker G, Versteeg R, Speleman F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 199410103–114. [DOI] [PubMed] [Google Scholar]
  • 16.Menten B, Buysse K, Vandesompele J, De Smet E, De Paepe A, Speleman F, Mortier G. Identification of an unbalanced X‐autosome translocation by array CGH in a boy with a syndromic form of chondrodysplasia punctata brachytelephalangic type. Eur J Med Genet 200548301–309. [DOI] [PubMed] [Google Scholar]
  • 17.Lupski J R, Stankiewicz P. Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 20051e49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Park S S, Stankiewicz P, Bi W, Shaw C, Lehoczky J, Dewar K, Birren B, Lupski J R. Structure and evolution of the Smith‐Magenis syndrome repeat gene clusters, SMS‐REPs. Genome Res 200212729–738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shaw C J, Lupski J R. Implications of human genome architecture for rearrangement‐based disorders: the genomic basis of disease. Hum Mol Genet 200413(Spec No. 1)R57–R64. [DOI] [PubMed] [Google Scholar]
  • 20.Stankiewicz P, Lupski J R. Genome architecture, rearrangements and genomic disorders. Trends Genet 20021874–82. [DOI] [PubMed] [Google Scholar]
  • 21.Ballif B C, Gajecka M, Shaffer L G. Monosomy 1p36 breakpoints indicate repetitive DNA sequence elements may be involved in generating and/or stabilizing some terminal deletions. Chromosome Res 200412133–141. [DOI] [PubMed] [Google Scholar]
  • 22.Ballif B C, Wakui K, Gajecka M, Shaffer L G. Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet 2004114198–206. [DOI] [PubMed] [Google Scholar]
  • 23.Gajecka M, Yu W, Ballif B C, Glotzbach C D, Bailey K A, Shaw C A, Kashork C D, Heilstedt H A, Ansel D A, Theisen A, Rice R, Rice D P, Shaffer L G. Delineation of mechanisms and regions of dosage imbalance in complex rearrangements of 1p36 leads to a putative gene for regulation of cranial suture closure. Eur J Hum Genet 200513139–149. [DOI] [PubMed] [Google Scholar]
  • 24.Feuk L, Carson A R, Scherer S W. Structural variation in the human genome. Nat Rev Genet 2006785–97. [DOI] [PubMed] [Google Scholar]
  • 25.Jurenka S B, Van Allen M I. Mixed sclerosing bone dysplasia, small stature, seizure disorder, and mental retardation: a syndrome? Am J Med Genet 1995576–9. [DOI] [PubMed] [Google Scholar]
  • 26.Hellemans J, Debeer P, Wright M, Janecke A, Kjaer K W, Verdonk P C, Savarirayan R, Basel L, Moss C, Roth J, David A, De Paepe A, Coucke P, Mortier G R. Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis. Hum Mutat 200627290. [DOI] [PubMed] [Google Scholar]
  • 27.Bianchi M E, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev 200515496–506. [DOI] [PubMed] [Google Scholar]
  • 28.Ligon A H, Moore S D, Parisi M A, Mealiffe M E, Harris D J, Ferguson H L, Quade B J, Morton C C. Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am J Hum Genet 200576340–348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Battista S, Fidanza V, Fedele M, Klein‐Szanto A J, Outwater E, Brunner H, Santoro M, Croce C M, Fusco A. The expression of a truncated HMGI‐C gene induces gigantism associated with lipomatosis. Cancer Res 1999594793–4797. [PubMed] [Google Scholar]
  • 30.Ashar H R, Fejzo M S, Tkachenko A, Zhou X, Fletcher J A, Weremowicz S, Morton C C, Chada K. Disruption of the architectural factor HMGI‐C: DNA‐binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 19958257–65. [DOI] [PubMed] [Google Scholar]
  • 31.Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, Van Den Berghe H, Dal Cin P. HMGI‐C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI‐C and HMGI(Y) genes. Lab Invest 200080359–369. [DOI] [PubMed] [Google Scholar]
  • 32.Bullerdiek J, Wobst G, Meyer‐Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 19936527–31. [DOI] [PubMed] [Google Scholar]
  • 33.Kazmierczak B, Pohnke Y, Bullerdiek J. Fusion transcripts between the HMGIC gene and RTVL‐H‐related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 199638223–226. [DOI] [PubMed] [Google Scholar]
  • 34.Kazmierczak B, Rosigkeit J, Wanschura S, Meyer‐Bolte K, Van de Ven W J, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J. HMGI‐C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 199612515–521. [PubMed] [Google Scholar]
  • 35.Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 199044153–167. [DOI] [PubMed] [Google Scholar]
  • 36.Sreekantaiah C, Leong S P, Karakousis C P, McGee D L, Rappaport W D, Villar H V, Neal D, Fleming S, Wankel A, Herrington P N.et al Cytogenetic profile of 109 lipomas. Cancer Res 199151422–433. [PubMed] [Google Scholar]
  • 37.Schoenmakers E F, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven W J. Recurrent rearrangements in the high mobility group protein gene, HMGI‐C, in benign mesenchymal tumours. Nat Genet 199510436–444. [DOI] [PubMed] [Google Scholar]
  • 38.Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J. Expression of HMGI‐C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 199719153–156. [DOI] [PubMed] [Google Scholar]
  • 39.Zhou X, Benson K F, Ashar H R, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI‐C. Nature 1995376771–774. [DOI] [PubMed] [Google Scholar]
  • 40.Benson K F, Chada K. Mini‐mouse: phenotypic characterization of a transgenic insertional mutant allelic to pygmy. Genet Res 19946427–33. [DOI] [PubMed] [Google Scholar]
  • 41.Hata Y, Nakanishi H, Takai Y. Synaptic PDZ domain‐containing proteins. Neurosci Res 1998321–7. [DOI] [PubMed] [Google Scholar]
  • 42.Dong H, O'Brien R J, Fung E T, Lanahan A A, Worley P F, Huganir R L. GRIP: a synaptic PDZ domain‐containing protein that interacts with AMPA receptors. Nature 1997386279–284. [DOI] [PubMed] [Google Scholar]
  • 43.Dong H, Zhang P, Song I, Petralia R S, Liao D, Huganir R L. Characterization of the glutamate receptor‐interacting proteins GRIP1 and GRIP2. J Neurosci 1999196930–6941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bruckner K, Pablo Labrador J, Scheiffele P, Herb A, Seeburg P H, Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 199922511–524. [DOI] [PubMed] [Google Scholar]
  • 45.Osten P, Khatri L, Perez J L, Kohr G, Giese G, Daly C, Schulz T W, Wensky A, Lee L M, Ziff E B. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron 200027313–325. [DOI] [PubMed] [Google Scholar]
  • 46.Contractor A, Rogers C, Maron C, Henkemeyer M, Swanson G T, Heinemann S F. Trans‐synaptic Eph receptor‐ephrin signaling in hippocampal mossy fiber LTP. Science 20022961864–1869. [DOI] [PubMed] [Google Scholar]
  • 47.Charych E I, Yu W, Li R, Serwanski D R, Miralles C P, Li X, Yang B Y, Pinal N, Walikonis R, De Blas A L. A four PDZ domain‐containing splice variant form of GRIP1 is localized in GABAergic and glutamatergic synapses in the brain. J Biol Chem 200427938978–38990. [DOI] [PubMed] [Google Scholar]
  • 48.Li R W, Serwanski D R, Miralles C P, Li X, Charych E, Riquelme R, Huganir R L, de Blas A L. GRIP1 in GABAergic synapses. J Comp Neurol 200548811–27. [DOI] [PubMed] [Google Scholar]
  • 49.Bladt F, Tafuri A, Gelkop S, Langille L, Pawson T. Epidermolysis bullosa and embryonic lethality in mice lacking the multi‐PDZ domain protein GRIP1. PNAS 2002996816–6821. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES